Sandoz Group AG
OTC: SDZNY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Richard Saynor
- Employees
- 22,678
- Headquarters
- Basel, Switzerland
- IPO year
- 2023
- Market cap
- $38.4B
- Website
- https://www.sandoz.com
Loading SDZNY…
Loading profile data…Frequently asked questions about SDZNY
What does Sandoz Group AG (SDZNY) do?
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, a...
Where does SDZNY trade?
Sandoz Group AG (SDZNY) trades on the Other OTC.
What sector is SDZNY in?
Sandoz Group AG (SDZNY) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Sandoz Group AG?
Richard Saynor is the chief executive officer of Sandoz Group AG (SDZNY).
Where is Sandoz Group AG headquartered?
Sandoz Group AG is headquartered in Switzerland.
Does SDZNY pay a dividend?
Yes — Sandoz Group AG (SDZNY) paid a trailing twelve-month dividend of USD 1.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SDZNY go public?
Sandoz Group AG (SDZNY) completed its initial public offering in 2023.